Nexalis Therapeutics Limited (ASX:NX1)
Australia flag Australia · Delayed Price · Currency is AUD
0.0090
-0.0010 (-10.00%)
At close: Sep 18, 2026

Nexalis Therapeutics Statistics

Total Valuation

ASX:NX1 has a market cap or net worth of AUD 2.53 million. The enterprise value is 2.46 million.

Market Cap2.53M
Enterprise Value 2.46M

Important Dates

The next estimated earnings date is Tuesday, December 1, 2026.

Earnings Date Dec 1, 2026
Ex-Dividend Date n/a

Share Statistics

ASX:NX1 has 253.04 million shares outstanding. The number of shares has increased by 4.04% in one year.

Current Share Class 253.04M
Shares Outstanding 253.04M
Shares Change (YoY) +4.04%
Shares Change (QoQ) +15.13%
Owned by Insiders (%) 33.14%
Owned by Institutions (%) 4.23%
Float 79.90M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.38
PB Ratio -1.36
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.31
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.46

Current Ratio 0.46
Quick Ratio 0.44
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -0.92
Interest Coverage -9.17

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -75.97%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 99.89%
Weighted Average Cost of Capital (WACC) 8.93%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.70
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -75.00% in the last 52 weeks. The beta is 0.16, so ASX:NX1's price volatility has been lower than the market average.

Beta (5Y) 0.16
52-Week Price Change -75.00%
50-Day Moving Average 0.02
200-Day Moving Average 0.03
Relative Strength Index (RSI) 39.32
Average Volume (20 Days) 380,954

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, ASX:NX1 had revenue of AUD 1.07 million and -2.06 million in losses. Loss per share was -0.01.

Revenue1.07M
Gross Profit 1.07M
Operating Income -1.86M
Pretax Income -2.06M
Net Income -2.06M
EBITDA n/a
EBIT -1.86M
Loss Per Share -0.01
Full Income Statement

Balance Sheet

The company has 791,334 in cash and 720,084 in debt, with a net cash position of 71,250 or 0.00 per share.

Cash & Cash Equivalents 791,334
Total Debt 720,084
Net Cash 71,250
Net Cash Per Share 0.00
Equity (Book Value) -1.86M
Book Value Per Share -0.01
Working Capital -1.88M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -770,327 and capital expenditures -14,430, giving a free cash flow of -784,757.

Operating Cash Flow -770,327
Capital Expenditures -14,430
Depreciation & Amortization 1,753
Net Borrowing 317,137
Free Cash Flow -784,757
FCF Per Share -0.00
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -174.69% and -193.64%.

Gross Margin 100.00%
Operating Margin -174.69%
Pretax Margin -193.64%
Profit Margin -193.64%
EBITDA Margin n/a
EBIT Margin -174.69%
FCF Margin n/a

Dividends & Yields

ASX:NX1 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -4.04%
Shareholder Yield -4.04%
Earnings Yield -81.51%
FCF Yield -31.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ASX:NX1 has an Altman Z-Score of -18.33 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -18.33
Piotroski F-Score 1